Cargando…
P1444: IMPACT OF CO-MORBIDITIES ON NON-RELAPSE MORTALITY AND CYTOKINE-RELEASE SYNDROME AFTER CD19 CAR-T CELL THERAPY - A RETROSPECTIVE STUDY FROM THE TCWP OF THE EBMT AND GOCART COALITION
Autores principales: | Basak, G., Peczynski, C., Koenecke, C., Terwel, S., Cabrerizo, Y., Penack, O., Moiseev, I., Schoemans, H., Fegueux, N., Potter, V., Zeerleder, S., Yakoub-Agha, I., Collin, M., Schanz, U., Dreger, P., Blaise, D., Besley, C., Glass, B., Mohty, M., Chabannon, C., Kuball, J., Snowden, J., Sureda, A., Kröger, N., Peric, Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430152/ http://dx.doi.org/10.1097/01.HS9.0000848632.89484.3a |
Ejemplares similares
-
Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party
por: Penack, Olaf, et al.
Publicado: (2023) -
Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party
por: Penack, Olaf, et al.
Publicado: (2023) -
Steroid-free first line treatment of moderate and severe chronic GVHD: a survey from the Transplant Complications Working Party of the EBMT
por: Moiseev, Ivan, et al.
Publicado: (2022) -
Association of pre-existing comorbidities with outcome of allogeneic hematopoietic cell transplantation. A retrospective analysis from the EBMT
por: Penack, Olaf, et al.
Publicado: (2021) -
Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP)
por: Sandler, Robert David, et al.
Publicado: (2020)